Characteristic | Number | Percentage |
---|---|---|
Age (years)a | ||
<40 | 1781 | 3.1 |
40–49 | 7020 | 12.3 |
50–59 | 16,651 | 29.1 |
60–69 | 15,779 | 27.6 |
70–79 | 10,482 | 18.3 |
80–89 | 4812 | 8.4 |
≥ 90 | 639 | 1.1 |
Raceb | ||
White | 50,250 | 87.9 |
Hispanic | 2220 | 3.9 |
Asian/Pacific Islander | 2135 | 3.7 |
Black | 1183 | 2.1 |
Other/mixed | 972 | 1.7 |
Missing | 404 | 0.7 |
Age at menarche (years)b | ||
<12 | 12,799 | 22.4 |
≥ 12 | 43,635 | 76.3 |
Missing | 730 | 1.3 |
Age at first full-term pregnancy (years)b | ||
Nulliparous | 14,157 | 24.8 |
< 25 | 15,171 | 26.5 |
≥ 25 | 26,909 | 47.1 |
Missing | 927 | 1.6 |
Total time breastfeeding (months)b | ||
Never or <12 | 40,567 | 71.0 |
≥ 12 | 15,446 | 27.0 |
Missing | 1,151 | 2.0 |
History of a benign breast biopsyb | ||
No | 47,812 | 83.6 |
Yes | 9175 | 16.1 |
Missing | 177 | 0.3 |
Family history of breast cancer (mother or sister)b | ||
No | 48,736 | 85.3 |
Yes | 6763 | 11.8 |
Missing data or participant was adopted | 1665 | 2.9 |
History of hospitalization for myocardial infarctionc | ||
No | 56,586 | 99.0 |
Yes | 578 | 1.0 |
History of diabetes mellitusa | ||
No | 54,433 | 95.2 |
Yes | 2715 | 4.8 |
Missing | 16 | 0.0 |
Strenuous plus moderate physical activity in the past 3 years (hours per week)a | ||
<3 | 26,079 | 45.6 |
≥3 | 30,909 | 54.1 |
Missing | 176 | 0.3 |
Alcohol consumption (grams per day)a | ||
None or <20 | 46,033 | 80.5 |
≥20 | 8652 | 15.1 |
Missing | 2479 | 4.3 |
Body mass index (kg/m2)a | ||
<25.0 | 29,509 | 51.6 |
25.0–29.9 | 16,619 | 29.1 |
≥30.0 | 10,359 | 18.1 |
Missing | 677 | 1.2 |
Menopausal status and hormone therapy (HT) usea | ||
Premenopausal | 6314 | 11.1 |
Perimenopausal or postmenopausal | ||
No HT in the last 5 years | 27,397 | 47.9 |
Used HT in the last 5 years, but not currently using | 10,142 | 17.7 |
Current HT use | 11,420 | 20.0 |
Unknown menopausal status or HT use | 1891 | 3.3 |
Regular-dose aspirin use at baselineb | ||
No NSAID used | 37,075 | 64.9 |
No regular-dose aspirin use, but used ibuprofen | 7002 | 12.3 |
Used 1–3 days/week | 6340 | 11.1 |
Used 4+ days/week | 5732 | 10.0 |
Unknown | 1015 | 1.8 |
Low-dose aspirin use at the 10-year follow upa | ||
Never in the past 3 years | ||
No NSAID use in the past 3 yearse | 21,421 | 37.5 |
No low-dose aspirin use, use of 1+ type(s) | 15,678 | 27.4 |
No low-dose aspirin use, unknown use of 1+ type(s) | 1829 | 3.2 |
Former | 2766 | 4.8 |
Current, 1–2 tablets/week | 915 | 1.6 |
Current, 3–4 tablets/week | 1163 | 2.0 |
Current, 5–6 tablets/week | 1406 | 2.5 |
Current, 7+ tablets/week | 10,421 | 18.2 |
Unknown | 1565 | 2.7 |
Regular-dose aspirin use at the 10-year follow upa | ||
Never in the past 3 years | ||
No NSAID use in the past 3 yearse | 21,421 | 37.5 |
No regular-dose aspirin use, use of 1+ type(s) | 23,451 | 41.0 |
No regular-dose aspirin use, unknown use for 1+ type(s) | 2253 | 3.9 |
Former/irregular | 2378 | 4.2 |
Current, 3+ tablets/week | 6387 | 11.2 |
Unknown | 1274 | 2.2 |
Ibuprofen use at the 10-year follow upa | ||
Never in the past 3 years | ||
No NSAID use in the past 3 yearse | 21,421 | 37.5 |
No ibuprofen use, use of 1+ type(s) | 18,219 | 31.9 |
No ibuprofen use, unknown use for 1+ type(s) | 1499 | 2.6 |
Former/irregular | 3679 | 6.4 |
Current, 3+ tablets/week | 10,382 | 18.2 |
Unknown | 1964 | 3.4 |
Other non-steroidal use at the 10-year follow upa | ||
Never in the past 3 years | ||
No NSAID use in the past 3 yearse | 21,421 | 37.5 |
No other non-steroidal use, use of 1+ type(s) | 25,529 | 44.7 |
No other non-steroidal use, unknown use for 1+ type(s) | 2307 | 4.0 |
Former/irregular | 2301 | 4.0 |
Current, 3+ tablets/week | 4263 | 7.5 |
Unknown | 1343 | 2.4 |
Cox-2 inhibitor use at the 10-year follow upa | ||
Never in the past 3 yearse | ||
No NSAID use in the past 3 yearse | 21,421 | 37.5 |
No Cox-2 inhibitor use, use of 1+ type(s) | 28,055 | 49.1 |
No Cox-2 inhibitor use, unknown use for 1+ type(s) | 2625 | 4.6 |
Former/irregular | 2807 | 4.9 |
Current, 3+ tablets/week | 1064 | 1.9 |
Unknown | 1192 | 2.1 |